EcoDrugPlus

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSDLEG00000009531
Gene Symbol: CYP17A1
4 Cross references
211 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSDLEG00000021625
Gene Symbol: CYP26A1
4 Cross references
208 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSDLEG00000000862
Gene Symbol: CYP46A1
4 Cross references
260 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSDLEG00000010625
Gene Symbol: DGAT1
1 Cross references
262 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSDLEG00000001578
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSDLEG00000012422
Gene Symbol: DPYD
3 Cross references
228 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSDLEG00000008636
Gene Symbol: DPP4
3 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSDLEG00000017901
Gene Symbol: DDR2
1 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSDLEG00000011094
Gene Symbol: DRD1
3 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSDLEG00000009777
Gene Symbol: DRD2
3 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSDLEG00000012960
Gene Symbol: DRD3
1 Cross references
209 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSDLEG00000003351
Gene Symbol: DRD4
1 Cross references
245 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).